Nplate (romiplostim) is a prescription drug that works to treat thrombocytopenia by activating bone marrow cells to make more platelets. Your response to this drug may vary based on your medical ...

Nplate (romiplostim) is a brand-name subcutaneous injection that’s prescribed to increase platelet levels (platelets are cells that help form blood clots) in certain situations. Nplate is not known to ...

Amgen’s Nplate (romiplostim) has demonstrated efficacy in treating thrombocytopaenia among gastrointestinal (GI) cancer patients, as Phase III RECITE results are presented at ASCO 2025. In the Phase ...

Amgen Inc. (NASDAQ:AMGN)’s thrombocytopenia drug Nplate (romiplostim) showed significant benefits in a Phase III trial for gastrointestinal (GI) cancer patients, as presented at the 2025 ASCO Annual ...